Literature DB >> 19285952

Topoisomerase IIalpha inhibition following DNA transfection greatly enhances random integration in a human pre-B lymphocyte cell line.

Eriko Toyoda1, Aya Kurosawa, Haruna Kamekawa, Noritaka Adachi.   

Abstract

DNA transfection can be too inefficient to establish a desired number of stable transfectants, particularly in lymphocytes; however, this could be circumvented by increasing the absolute frequency of random integration. In this paper, we show that treating cells with topoisomerase II inhibitor following electroporation greatly (approximately 10- to 20-fold) enhances random integration of input DNA in a human pre-B lymphocyte cell line, Nalm-6. With the use of various kinds of topoisomerase II-targeting agents, we also present evidence that topoisomerase IIalpha inhibition is critical for the enhancement of random integration, while the contribution of topoisomerase IIbeta may be negligible. As topoisomerase IIalpha is highly expressed in vigorously growing cells, our results show that topoisomerase IIalpha inhibition provides a promising way of enhancing random integration in virtually all cultured cell lines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285952     DOI: 10.1016/j.bbrc.2009.03.047

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Optimization of Gene Transfection in Murine Myeloma Cell Lines using Different Transfection Reagents.

Authors:  Mahdi Shabani; Sheyda Hemmati; Reza Hadavi; Zahra Amirghofran; Mahmood Jeddi-Tehrani; Hodjatallah Rabbani; Fazel Shokri
Journal:  Avicenna J Med Biotechnol       Date:  2010-07

2.  Low dose ionizing radiation strongly stimulates insertional mutagenesis in a γH2AX dependent manner.

Authors:  Alex N Zelensky; Mascha Schoonakker; Inger Brandsma; Marcel Tijsterman; Dik C van Gent; Jeroen Essers; Roland Kanaar
Journal:  PLoS Genet       Date:  2020-01-16       Impact factor: 5.917

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.